When you are dealing with a low-priced, low volume stock like THLD, words like volatility tend to lose their meaning. Is a 10%+ price swing due to someone forgetting to put a limit on his purchase order or was it the case of an investor wishing to start or increase their position in the company and recognizing that in the long run whether you pay $1.30 for 5,000 shares or $1.50 isn't going to matter much. With these biotech stocks, you never know when that one news item will come out that might ratchet the stock up 50%+, so if you want to build a meaningful position, do you spend a month waiting for small sellers to take your $1.30 bid, or do you bite the bullet and just put a limit order in at $1.50? In the end, with a company like THLD, we're all just "idiots speculating" until they generate some meaningful clinical data.
Thanks for your input....you are right...but their results so far look good...a partner is needed to bring the clinical trials to a conclusion and hopefully a successful one. We do need news and I guess volatility is the name of the game with thld, at least lately it seems to be.